Loading data for FTXH — first visit, this takes a few seconds.
First Trust Nasdaq Pharma... (FTXH)
: FTXH
· Precio en tiempo real · USD
n/a
n/a (n/a)
Al cierre: Invalid Date
First Trust Nasdaq Pharmaceuticals ETF (FTXH): precio, posiciones y análisis del ETF
No hay datos disponibles
| Precio de compra | n/a |
| Capitalización de mercado | n/a |
| AUM | 911.09M |
| NAV | 40.17 |
| Beta | 0.45 |
| EPS (ttm) | n/a |
| Relación PE (ttm) | n/a |
| Acciones en circulación | n/a |
| Fecha de inicio | Sep 20, 2016 |
| Precio de venta | n/a |
| Volumen | n/a |
| Volumen medio (20D) | n/a |
| Abierto | n/a |
| Cierre anterior | n/a |
| Rango del día | n/a - n/a |
| Rango de 52 semanas | n/a - n/a |
| Participaciones | n/a |
| Relación de gastos | 0.60% |
Acerca de FTXH
The fund will normally invest at least 80% of its net assets (including investment borrowings) in the securities that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and ranking. It is non-diversified.
Clase de activo Equity
Símbolo bursátil FTXH
Fecha de inicio Sep 20, 2016
Proveedor First Trust
Sitio web Página de inicio del fondo
Intercambio n/a
Las 10 principales participaciones 52.94% de activos
| Nombre | Símbolo | Peso |
|---|---|---|
| Abbvie Inc | ABBV | 7.39% |
| Eli Lilly And Co | LLY | 7.29% |
| Merck & Co Inc | MRK | 6.99% |
| Bristol-myers Squibb... | BMY | 6.93% |
| Johnson & Johnson | JNJ | 6.87% |
| Viatris Inc | VTRS | 3.97% |
| Biogen Inc | BIIB | 3.61% |
| Amgen Inc | AMGN | 3.34% |
| Cardinal Health Inc | CAH | 3.31% |
| Vertex Pharmaceutica... | VRTX | 3.24% |